A new criteria differentiating type 2 and 3 Brugada patterns from ordinary incomplete right bundle branch block.

The type 1 (coved) ECG pattern is diagnostic for Brugada syndrome; types 2 and 3 require antiarrhythmic drug challenge to confirm its presence. We evaluated a 12-lead ECG-based criterion to differentiate between ordinary incomplete right bundle branch block (iRBBB) and true type 2 and 3 patterns that evolve toward type 1 during drug challenge. The subjects were 22 patients (21 men, 1 woman; mean age, 46.8 ± 13.2 years) referred for drug challenge (1 mg/kg pilsicainide, iv). In magnified ECG lead V1 and/or V2 with an iRBBB pattern, the baseline angle defined as the cross section of the upslope of the r' wave with the downslope of the r' wave was measured and compared between patients responding negatively versus positively to drug challenge, and was found to be significantly smaller in patients responding negatively (20.9 ± 12.9°, n = 6, versus 38.7 ± 16.5°, n = 13; P = 0.009). This ECG-based method successfully discriminates between the ordinary iRBBB pattern and drug-induced evolution toward a type 1 Brugada ECG.

[1]  V. Probst,et al.  Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. , 2008, Heart rhythm.

[2]  P. C. Viswanathan,et al.  Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias , 2007, Circulation.

[3]  Y. Aizawa,et al.  Incidence and Initial Characteristics of Pilsicainide‐Induced Ventricular Arrhythmias in Patients With Brugada Syndrome , 2007, Pacing and clinical electrophysiology : PACE.

[4]  Michel Haïssaguerre,et al.  Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death , 2007, Circulation.

[5]  Hiroaki Tatsumi,et al.  Risk Stratification in Patients with Brugada Syndrome: Analysis of Daily Fluctuations in 12‐Lead Electrocardiogram (ECG) and Signal‐Averaged Electrocardiogram (SAECG) , 2006, Journal of cardiovascular electrophysiology.

[6]  J. A. Gomes,et al.  Risk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis , 2006, Journal of cardiovascular electrophysiology.

[7]  T. Ikeda,et al.  Noninvasive Risk Stratification of Subjects with a Brugada‐Type Electrocardiogram and No History of Cardiac Arrest , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[8]  J. Brugada,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[9]  G. Breithardt,et al.  Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome , 2005, Circulation.

[10]  J. Brugada,et al.  Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest , 2003, Circulation.

[11]  H. Morita,et al.  Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. , 2003, Journal of the American College of Cardiology.

[12]  J. Towbin,et al.  Brugada syndrome: 1992-2002: a historical perspective. , 2003, Journal of the American College of Cardiology.

[13]  R. Hauer,et al.  Proposed diagnostic criteria for the Brugada syndrome: consensus report. , 2002, Circulation.

[14]  S. Priori,et al.  Natural History of Brugada Syndrome: Insights for Risk Stratification and Management , 2002, Circulation.

[15]  S. Priori,et al.  Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families , 2000, Circulation.

[16]  J. Towbin,et al.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.

[17]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[18]  J. Brugada,et al.  Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. , 1998, Circulation.

[19]  Y. Aizawa,et al.  Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. , 1996, Journal of the American College of Cardiology.

[20]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.